Mesoporous silicon nano particles having properties of stimulation response and split-warehouse intelligent drug carrying and release and preparation method of mesoporous silicon nano particles
A stimuli-response, nanoparticle technology, applied in the field of nanomaterials, can solve problems such as side reactions, affecting curative effect, etc., and achieve the effects of low cost, convenient operation and simple device
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0046] Preparation of mesoporous silicon nanoparticles with stimuli-responsive and intelligent drug-loading and drug-releasing properties, the steps are as follows:
[0047] 1) Preparation of mesoporous silicon nanoparticles: Dissolve 0.5gCTAB and 0.015gNaOH in 480mL deionized water and stir vigorously, then heat to 80°C, stir evenly to obtain a mixed solution, and then slowly drop 2.5gTEOS into the above mixed solution , the dropping speed is 10d / min, and the reaction is carried out under vigorous stirring at 80°C for 2h, and centrifuged (8000r / min, 10min) to obtain a white solid, which is washed several times with secondary water and methanol, and vacuum-dried to obtain a white solid with a surface MCM-41 type mesoporous silicon nanoparticles (CTAB@MSN) of active agent CTAB;
[0048] 2) Preparation of mercaptolated mesoporous silicon nanoparticles containing surfactant: Take 1.3g CTAB@MSN and disperse it in 108mL methanol, ultrasonically disperse it evenly, then add 1.3g 3-m...
Embodiment 2
[0055] The method similar to Example 1 was used to prepare mesoporous silicon nanoparticles with stimuli-response and intelligent drug-loading and drug-release characteristics in separate compartments, except that:
[0056] 6) Preparation of DOX-loaded reduction-responsive mesoporous silicon drug-controlled release system (DOX@MSN-SS-CD): 100 mg of MSN-SS-alkyne was dispersed in 5 mL of methanol and 5 mL of PBS buffer with a pH value of 7.0 under dark conditions After ultrasonically dispersing uniformly, 30 mg of doxorubicin hydrochloride (DOX·HCl) was added, and the reaction mixture was vigorously stirred at room temperature for 24 h. Then add 50mg mono-6-azido-β-CD, 50mg CuSO 4 ·5H 2 O and 75 mg of sodium ascorbate were reacted at room temperature for 3 days under the protection of a nitrogen atmosphere, centrifuged and washed several times with secondary water and methanol, and vacuum-dried to obtain a reduction-responsive mesoporous plugged with cyclodextrin loaded with d...
Embodiment 3
[0059] Preparation of mesoporous silicon nanoparticles with stimuli-responsive and intelligent drug-loading and drug-releasing properties, the steps are as follows:
[0060] 1) Preparation of mesoporous silicon nanoparticles: Dissolve 0.2gCTAB and 0.014gNaOH in 480mL deionized water and stir vigorously, then heat to 80°C, stir evenly to obtain a mixed solution, then slowly add 1.6gTEOS dropwise to the above solution, The dropping speed is 15d / min, and the reaction is carried out under vigorous stirring at 70°C for 2 hours, centrifuged to obtain a white solid, which is washed several times with secondary water and methanol, and vacuum-dried to obtain the MCM-41 type with surfactant CTAB Mesoporous silicon nanoparticles (CTAB@MSN);
[0061]2) Preparation of mercaptolated mesoporous silicon nanoparticles containing surfactant (MSN-SH): Take 1.3g CTAB@MSN and disperse it in 108mL methanol, ultrasonically disperse it evenly, then add 2.6g 3-mercaptopropyltrimethyl Oxysilane was vi...
PUM
Property | Measurement | Unit |
---|---|---|
Particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com